BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15735404)

  • 21. Cardiac application of embryonic stem cells.
    Xiao YF
    Sheng Li Xue Bao; 2003 Oct; 55(5):493-504. PubMed ID: 14566394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Administration of allogenic stem cells dosed to secure cardiogenesis and sustained infarct repair.
    Behfar A; Hodgson DM; Zingman LV; Perez-Terzic C; Yamada S; Kane GC; Alekseev AE; Pucéat M; Terzic A
    Ann N Y Acad Sci; 2005 May; 1049():189-98. PubMed ID: 15965118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multipotent fetal-derived Cdx2 cells from placenta regenerate the heart.
    Vadakke-Madathil S; LaRocca G; Raedschelders K; Yoon J; Parker SJ; Tripodi J; Najfeld V; Van Eyk JE; Chaudhry HW
    Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11786-11795. PubMed ID: 31109997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-coding RNAs in Cardiac Regeneration.
    van der Ven CFT; Hogewoning BCR; van Mil A; Sluijter JPG
    Adv Exp Med Biol; 2020; 1229():163-180. PubMed ID: 32285411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial regeneration with bone-marrow-derived stem cells.
    Yoon YS; Lee N; Scadova H
    Biol Cell; 2005 Apr; 97(4):253-63. PubMed ID: 15762847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac repair with pluripotent stem cell-derived cardiomyocytes: Proof of concept but new challenges.
    Masoudpour H; Laflamme MA
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):945-948. PubMed ID: 28688708
    [No Abstract]   [Full Text] [Related]  

  • 27. Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.
    Glass C; Singla DK
    Cell Transplant; 2012; 21(9):1931-44. PubMed ID: 22449760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias.
    Romagnuolo R; Masoudpour H; Porta-Sánchez A; Qiang B; Barry J; Laskary A; Qi X; Massé S; Magtibay K; Kawajiri H; Wu J; Valdman Sadikov T; Rothberg J; Panchalingam KM; Titus E; Li RK; Zandstra PW; Wright GA; Nanthakumar K; Ghugre NR; Keller G; Laflamme MA
    Stem Cell Reports; 2019 May; 12(5):967-981. PubMed ID: 31056479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives.
    Lui KO; Bu L; Li RA; Chan CW
    Birth Defects Res C Embryo Today; 2012 Mar; 96(1):98-108. PubMed ID: 22457181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiogenic differentiation and transdifferentiation of progenitor cells.
    Reinecke H; Minami E; Zhu WZ; Laflamme MA
    Circ Res; 2008 Nov; 103(10):1058-71. PubMed ID: 18988903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial regeneration: the role of progenitor cells derived from bone marrow and heart.
    Wang X; From AH; Zhang J
    Prog Mol Biol Transl Sci; 2012; 111():195-215. PubMed ID: 22917232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
    Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
    Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human embryonic stem cell transplantation to repair the infarcted myocardium.
    Leor J; Gerecht S; Cohen S; Miller L; Holbova R; Ziskind A; Shachar M; Feinberg MS; Guetta E; Itskovitz-Eldor J
    Heart; 2007 Oct; 93(10):1278-84. PubMed ID: 17566061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac stem cell therapy: review of the native cardiac progenitor cells and future direction.
    Ye J; Yeghiazarians Y
    J Cardiovasc Pharmacol; 2014 Feb; 63(2):85-94. PubMed ID: 23674056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human embryonic stem cells and cardiac repair.
    Zhu WZ; Hauch KD; Xu C; Laflamme MA
    Transplant Rev (Orlando); 2009 Jan; 23(1):53-68. PubMed ID: 18657407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comments about possible use of human embryonic stem cell-derived cardiomyocytes to direct autologous adult stem cells into the cardiomyogenic lineage.
    Heng BC; Haider HK; Sim EK; Cao T; Tong GQ; Ng SC
    Acta Cardiol; 2005 Feb; 60(1):7-12. PubMed ID: 15779844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The infarcted cardiac microenvironment cannot selectively promote embryonic stem cell differentiation into cardiomyocytes.
    Chen YR; Li Y; Chen L; Yang XC; Su PX; Cai J
    Cardiovasc Pathol; 2011; 20(2):77-83. PubMed ID: 20117024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress and Challenge of Cardiac Regeneration to Treat Heart Failure.
    Isomi M; Sadahiro T; Ieda M
    J Cardiol; 2019 Feb; 73(2):97-101. PubMed ID: 30420106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human embryonic stem cells for myocardial regeneration.
    Kehat I; Gepstein L
    Heart Fail Rev; 2003 Jul; 8(3):229-36. PubMed ID: 12878831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiating the naturally occurring process for repair of damaged heart.
    Li M; Ng SC
    Curr Pharm Des; 2014; 20(12):1950-63. PubMed ID: 23844738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.